Back
Live market summary

COVID-19 is favored at 15% as of 4 Oct 2026, 04:35 UTC across 6 markets.

  • COVID-19: 15% (24h change +1%)
  • Influenza: 13% (24h change 0%)
  • Polio: 4% (24h change 0%)
  • Hepatitis B: 3.6% (24h change 0%)
  • Rotavirus: 2% (24h change 0%)
  • Dengue: 1% (24h change 0%)
policy6 marketsLIVE

Which vaccines will the CDC no longer recommend in 2026?

Trade ↗

Odds history

Loading chart

All options

COVID-19

15%
Trade ↗
About this market

Market question: Which vaccines will the CDC no longer recommend in 2026?

How to read these odds

Each percentage is the latest traded Kalshi price for that option. A 62% contract price implies a 62% market-estimated chance, but prediction markets can move quickly and are not polls.

Market odds FAQ

Who is favored in Which vaccines will the CDC no longer recommend in 2026?

COVID-19 is favored at 15% as of 4 Oct 2026, 04:35 UTC, based on live Kalshi prediction-market prices.

What are the current odds for Which vaccines will the CDC no longer recommend in 2026?

COVID-19: 15%; Influenza: 13%; Polio: 4%; Hepatitis B: 3.6%; Rotavirus: 2%; Dengue: 1%. These are live market prices.

Where do these odds come from?

Each probability is a traded price from Kalshi, a CFTC-regulated prediction-market exchange. A contract trading at 62¢ implies a 62% market-estimated chance. ElectionOdds displays the data and does not create its own forecast.